Clinical Trials Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLCAugust 8, 2026
Clinical Trials A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell CarcinomaAugust 7, 2026